Immunogenic rhinovirus peptides
AssigneeGlaxosmithkline Biologicals SA
InventorsGuy Baudoux, Mathieu Boxus, Brigitte Colau, Martine Marchand
Life of this patent
Estimating the term…
Abstract
Fusion proteins comprising a carrier protein and a Human Rhinovirus (HRV) peptide, and immunogenic compositions containing such fusion proteins.
Claims12
An immunogenic composition comprising (a) a fusion protein, said fusion protein comprising a carrier protein coupled to a human rhinovirus (HRV) peptide of no more than 40 amino acids, said HRV peptide comprising a sequence selected from SEQ ID NO:
- 1;
- and (b) a pharmaceutically acceptable diluent, excipient or carrier.
A fusion protein comprising a carrier protein coupled to a HRV peptide of no more than 40 amino acids, said HRV peptide comprising a sequence selected from SEQ ID NO:
- 1.
A method for preparing an immunogenic composition, the method comprising combining (a) a fusion protein comprising a carrier protein coupled to a human rhinovirus (HRV) peptide of no more than 40 amino acids, said HRV peptide comprising a sequence selected from SEQ ID NO:
- 1;
- and (b) a pharmaceutically acceptable diluent, excipient, or carrier.
Dependencies are inferred from the claim text.